Generation and protective activities of human monoclonal antibodies against Pseudomonas aeruginosa
Sawada, S.; Kawamura, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 49(10): 2441-2445
1991
ISSN/ISBN: 0047-1852 PMID: 1749101 Document Number: 368274
Document emailed within 1 workday
Related Documents
Vetkova, L.G.; Zaĭtsev, L.G.; Khasman, E.L.; Radkevich, S.A.; Moroz, A.F. 1986: Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 14-18Bermudez, L.E. 1986: The use of monoclonal antibodies in the diagnosis of partially treated Pseudomonas aeruginosa meningitis: patient report Brazilian Journal of Medical and Biological Research 19(2): 159-165
Sastry, K.S.R.; Tuteja, U.; Batra, H.V. 2003: Generation and characterization of monoclonal antibodies to protective antigen of Bacillus anthracis Indian Journal of Experimental Biology 41(2): 123-128
Doi, T.; Yoshioka, M.; Nakajima, T. 1976: Pseudomonas aeruginosa antibodies in human plasma Japanese Journal of Experimental Medicine 46(3): 149-154
Stanislavskiĭ, E.S.; Palkina, N.A.; Bulk, V.F.; Zhvanetskaia, M.I.; Chekan, L.V. 1981: Cell-free Pseudomonas vaccine. II. Isolation and immunological properties of protective antigens of Pseudomonas aeruginosa Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 8: 37-40
Treshchanina, N.A.; Nesmeianova, M.A.; Zhdan-Pushkina, S.M. 1981: Exogenous orthophosphate regulation of the phosphohydrolase activities of Pseudomonas aeruginosa and Pseudomonas maltophilia Mikrobiologiia 50(6): 996-1001
Edvabnaia, L.S.; Zaĭdner, I.G.; Makarenko, T.A.; Bulk, V.F.; Zhvanetskaia, M.I. 1985: Protective protein antigens of Pseudomonas aeruginosa Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 11: 18-23
Huber, M.; Vor Dem Esche, U.; Grunow, R.; Bessler, W.G. 2005: Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin Drugs under Experimental and Clinical Research 31(2): 35-43
Grishina, I.A.; Kolker, I.I.; Stanislavskiĭ, E.S.; Zhvanetskaia, M.I.; Palkina, M.I. 1980: Protective properties of antigenic preparations of Pseudomonas aeruginosa Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 63-67
Stanislavskiĭ, E.S.; Iushkova, N.A.; Landsman, N.M. 1983: Protective cross activity of the extracellular mucus of Pseudomonas aeruginosa Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 72-77
Cha, S.C.; Bass, J.A.; Shetlar, M.R. 1971: Composition of the protective antigen from the slime layer of Pseudomonas aeruginosa Texas Reports on Biology and Medicine 29(3): 265-272
Shigeta, S.; Goto, S.; Ishida, N. 1971: Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isolated from clinical specimens Rinsho Byori. Japanese Journal of Clinical Pathology 19(1): 77-80
Puri, J.; Revathi, G.; Kundra, P.; Talwar, V. 1996: Activity of third generation cephalosporins against Pseudomonas aeruginosa in high risk hospital units Indian Journal of Medical Sciences 50(7): 239-243
Palkina, N.A.; Bulk, V.F.; Zhvanetskaia, M.I.; Stakislavskiĭ, E.S.; Kolker, I.I. 1978: Immunological study of cellular components of Pseudomonas aeruginosa. IV. Fractionation of Pseudomonas aeruginosa mucus by diafiltration and biological properties of isolated fractions Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 50-55
Kholodkova, E.V.; Fedotova, I.M.; Stanislavskiĭ, E.S. 1987: Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 8: 47-50
Furukawa, K.; Yamaguchi, H.; Oettgen, H.F.; Old, L.J.; Lloyd, K.O. 1989: Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies Cancer Research 49(1): 191-196
Okada, K.; Kawaharajo, K.; Kasai, T.; Homma, J.Y. 1980: Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection Japanese Journal of Experimental Medicine 50(1): 53-61
Friedman, S.M.; Hunter, S.B.; Irigoyen, O.H.; Kung, P.C.; Goldstein, G.; Chess, L. 1981: Functional analysis of human T cell subsets defined by monoclonal antibodies. II. Collaborative T-T interactions in the generation of TNP-altered-self-reactive cytotoxic T lymphocytes Journal of Immunology 126(5): 1702-1705
Ishida, H.; Ishida, Y.; Kurosaka, Y.; Otani, T.; Sato, K.; Kobayashi, H. 1998: In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa Antimicrobial Agents and ChemoTherapy 42(7): 1641-1645
Salageanu, A.; Ceacareanu, B.; Popescu, D.; Istrate, N.; Szegli, G. 1998: Experimental studies on bacterial product CANTASTIM derived from Pseudomonas aeruginosa. II. Protective effect in Salmonella typhimurium infection Roumanian Archives of Microbiology and Immunology 56(1-2): 17-26